Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 22, 2022--
The "Global Viral Vectors Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.
The viral vectors market is poised to grow by $490.64 mn during 2022-2026, accelerating at a CAGR of 14.23% during the forecast period. The report on the viral vectors market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, increasing use of viral vectors to develop gene therapies and vaccines and growing funding for and investments in gene therapies and vaccines.
The viral vectors market analysis includes the application segment and geographic landscape.
The viral vectors market is segmented as below: By Application
By Geographical Landscape
This study identifies the increasing number of R&D activities for the development of gene therapies and vaccines using viral vectors as one of the prime reasons driving the viral vector market growth during the next few years. Also, the rising number of M&A and collaborations and the emergence of novel technologies to manufacture viral vectors will lead to sizable demand in the market.
The report on the viral vectors market covers the following areas:
Key Topics Covered:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Application
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/wgvi6b
View source version on businesswire.com:https://www.businesswire.com/news/home/20220922005707/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.comFor E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: EUROPE UNITED STATES NORTH AMERICA ASIA PACIFIC
INDUSTRY KEYWORD: HEALTH GENETICS OTHER SCIENCE RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/22/2022 10:42 AM/DISC: 09/22/2022 10:42 AM
http://www.businesswire.com/news/home/20220922005707/en